SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001532176-13-000008
Filing Date
2013-05-03
Accepted
2013-05-03 10:20:35
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q regn-33113x10q.htm 10-Q 1335854
2 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) regn-ex_311x3312013x10q.htm EX-31.1 15191
3 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) regn-ex_312x3312013x10q.htm EX-31.2 15644
4 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 regn-ex_32x3312013x10q.htm EX-32 6679
  Complete submission text file 0001532176-13-000008.txt   6697651

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT regn-20130331.xml EX-101.INS 1100302
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20130331.xsd EX-101.SCH 32383
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT regn-20130331_cal.xml EX-101.CAL 64522
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT regn-20130331_def.xml EX-101.DEF 196405
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20130331_lab.xml EX-101.LAB 455338
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20130331_pre.xml EX-101.PRE 248156
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 13810753
SIC: 2834 Pharmaceutical Preparations